Abstract
Dipeptidyl-peptidase IV is an enzyme involved in a lot of biochemical processes, where it modifies a number of regulatory proteins by removing the terminal peptides by hydrolysis. Here we describe a histochemical method to demonstrate with accuracy and precision its in situ activity on cryostatic section of Wistar rat liver by means of a simultaneous azo-coupling method.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Pro B, Dang NH (2004) CD26/dipeptidyl peptidase IV and its role in cancer. Histol Histopathol 19:1345–1351
Ohnuma K, Hosono O, Dang NH, Morimoto C (2011) Dipeptidyl peptidase in autoimmune pathophysiology. Adv Clin Chem 53:51–84
Gorrell MD, Abbott CA, Kähne T et al (2000) Relating structure to function in the beta-propeller domain of dipeptidylpeptidase IV. Point mutations that influence adenosine deaminase binding, antibody binding and enzyme activity. In: Langner J, Ansorge S (eds) Cellular peptidases in immune functions and diseases 2. Kluwer, New York, NY, pp 89–95
Ohnuma K, Inoue H, Uchiyama M, Yamochi T, Hosono O, Dang NH, Morimoto C (2006) T-cell activation via CD26 and caveolin-1 in rheumatoid synovium. Mod Rheumatol 6(1):3–13
Tarantola E, Bertone V, Milanesi G et al (2012) DipeptidylpeptidaseIV, a key enzyme for the degradation of incretins and neuropeptides: activity and expression in the liver of lean and obese rats. Eur J Histochem 56:e41
Mentlein R (1999) Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides. Regul Pept 85:9–24
Mentlein R (2009) Mechanisms underlying the rapid degradation and elimination of the incretin hormones GLP-1 and GIP. Best Pract Res Clin Endocrinol Metab 4:443–452
Hildebrandt M, Rose M, Mayr C et al (2000) Dipeptidyl peptidase IV (DPP IV, CD26) in patients with mental eating disorders. Adv Exp Med Biol 477:197–204
Gorrell MD (2005) Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders. Clin Sci 108:1–16
Itou M, Kawaguchi T, Taniguchi E, Sata M (2013) Dipeptidyl peptidase-4: a key player in chronic liver disease. World J Gastroenterol 19:2298–2306
Miyazaki M, Kato M, Tanaka K et al (2012) Increased hepatic expression of dipeptidyl peptidase-4 in non-alcoholic fatty liver disease and its association with insulin resistance and glucose metabolism. Mol Med Report 5:729–733
Williams KH, Shackel NA, Gorrell MD et al (2013) Diabetes and nonalcoholic fatty liver disease: a pathogenic duo. Endocr Rev 34:84–129
Kesty NC, Roth JD, Maggs D (2008) Hormone based therapies in the regulation of fuel metabolism and body weight. Expert Opin Biol Ther 8:1733–1747
Chyan YJ, Chuang LM (2007) Dipeptidyl peptidase-IV inhibitors: an evolving treatment for type 2 diabetes from the incretin concept. Recent Pat Endocr Metab Immun Drug Discov 1:15–24
DiStefano JK, Watanabe RM (2010) Pharmacogenetics of anti-diabetes drugs. Pharmaceuticals (Basel) 3:2610–2646
Martin JH, Deacon CF, Gorrell MD, Prins JB (2011) Incretin-based therapies-review of the physiology, pharmacology and emerging clinical experience. Intern Med J 41:299–307
Bergmann K, Sypniewska G (2013) Diabetes as a complication of adipose tissue dysfunction. Is there a role for potential new biomarkers? Clin Chem Lab Med 51:177–185
Piazza GA, Callanan HM, Mowery J et al (1989) Evidence for a role of dipeptidyl peptidase IV in fibronectin-mediated interactions of hepatocytes with extracellular matrix. Biochem J 262:327–334
Balaban YH, Korkusuz P, Simsek H et al (2007) Dipeptidyl peptidase IV (DDP IV) in NASH patients. Ann Hepatol 6(4):242–250
Wang XM, Yao TW, Nadvi NA et al (2008) Fibroblast activation protein and chronic liver disease. Front Biosci 13:3168–3180
Gorrell MD, Gysbers V, McCaughan GW (2001) CD26: a multifunctional integral membrane and secreted protein of activated lymphocytes. Scand J Immunol 54:249–264
Gonzalez-Gronow M, Hershfield MS, Arredondo-Vega FX et al (2001) Cell surface adenosine deaminase binds and stimulates plasminogen activation on 1-LN human prostate cancer cells. J Biol Chem 279:20993–20998
Matheeussen V, Jungraithmayr W, De Meester I (2012) Dipeptidyl peptidase 4 as a therapeutic target in ischemia/reperfusion injury. Pharmacol Ther 136:267–282
Ou X, O’Leary HA, Broxmeyer HE (2013) Implications of DPP4 modification of proteins that regulate stem/progenitor and more mature cell types. Blood 122:161–169
Batra S, Kuo C, Rakusan K (1989) Spatial distribution of coronary capillaries: A-V segment staggering. Adv Exp Med Biol 248:241–247
Batra S, Konig MF, Cruz-Orives LM (1995) Unbiased estimation of capillary length from vertical slices. J Microscopy 178(Pt 2):152–159
Dimitrova D, Tashkova S, Dikov A et al (2002) Enzyme activities of human milk cells. Comptes rendus de l’Academie Bulgare des Sciences, Tome, p 55
Lojda Z, Gossrau R, Schiebler TH (1979) Enzyme histochemistry.A laboratory manual. Springer, Berlin
Van Noorden CJF, Fredericks WM (1992) Enzyme histochemistry. A laboratory manual of current methods. Oxford Science Publications. Oxford University Press – Royal Microscopy Society, Oxford
Horobin RW (1982) Histochemistry. Pag 135, Fig. 47. Fisher & Butterworths eds
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Bertone, V., Tarantola, E., Freitas, I. (2017). Enzyme-Histochemistry Technique for Visualizing the Dipeptidyl-Peptidase IV (DPP-IV) Activity in the Liver Biliary Tree. In: Pellicciari, C., Biggiogera, M. (eds) Histochemistry of Single Molecules. Methods in Molecular Biology, vol 1560. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6788-9_3
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6788-9_3
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6787-2
Online ISBN: 978-1-4939-6788-9
eBook Packages: Springer Protocols